AbbVie Inc. - Common Stock (ABBV) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
ABBV on NYSE
Shares outstanding
1,767,364,935
Price per share
$228.49
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
1,269,475,738
Total reported value
$293,671,005,777
% of total 13F portfolios
0.26%
Share change
-18,777,053
Value change
-$3,153,006,176
Number of holders
3,852
Price from insider filings
$228.49
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of AbbVie Inc. - Common Stock (ABBV) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 10% $33,326,140,164 177,266,703 The Vanguard Group 30 Jun 2025

As of 30 Sep 2025, 3,852 institutional investors reported holding 1,269,475,738 shares of AbbVie Inc. - Common Stock (ABBV). This represents 72% of the company’s total 1,767,364,935 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of AbbVie Inc. - Common Stock (ABBV) together control 46% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 10% 177,747,261 +0.25% 0.62% $41,155,600,812
BlackRock, Inc. 8.3% 145,977,089 -1% 0.6% $33,799,535,063
STATE STREET CORP 4.5% 79,821,657 -0.25% 0.64% $18,481,906,462
JPMORGAN CHASE & CO 3.2% 56,534,816 -1.2% 0.83% $13,090,131,914
MORGAN STANLEY 2.4% 41,654,784 -0.11% 0.58% $9,644,749,545
GEODE CAPITAL MANAGEMENT, LLC 2.3% 40,439,493 +3.2% 0.6% $9,333,681,014
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.5% 25,958,106 -3.1% 0.96% $6,008,458,551
Capital Research Global Investors 1.4% 25,230,830 -0.14% 1.1% $5,841,881,609
BANK OF AMERICA CORP /DE/ 1.4% 25,154,905 +0.18% 0.44% $5,824,366,747
NORTHERN TRUST CORP 1.2% 22,046,227 +0.15% 0.65% $5,104,583,401
FMR LLC 1.2% 21,035,087 +0.16% 0.25% $4,870,464,147
FRANKLIN RESOURCES INC 0.82% 14,551,400 -3.7% 0.84% $3,369,230,980
GOLDMAN SACHS GROUP INC 0.76% 13,395,219 +10% 0.45% $3,101,529,160
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC 0.71% 12,581,121 -14% 0.63% $2,913,032,756
Bank of New York Mellon Corp 0.7% 12,301,919 -1.6% 0.51% $2,848,386,477
Legal & General Group Plc 0.68% 12,004,084 +4.3% 0.62% $2,779,425,606
UBS Group AG 0.66% 11,718,236 -0.73% 0.53% $2,713,240,363
Capital International Investors 0.61% 10,703,532 -22% 0.4% $2,476,737,567
PRICE T ROWE ASSOCIATES INC /MD/ 0.6% 10,602,227 +17% 0.26% $2,454,841,000
WELLINGTON MANAGEMENT GROUP LLP 0.6% 10,536,901 +457% 0.43% $2,439,714,057
Amundi 0.59% 10,508,317 +16% 0.78% $2,418,909,492
AMERIPRISE FINANCIAL INC 0.55% 9,675,877 +4.4% 0.52% $2,241,362,587
RAYMOND JAMES FINANCIAL INC 0.54% 9,557,701 +2.4% 0.71% $2,212,110,461
DEUTSCHE BANK AG\ 0.54% 9,456,032 +3% 0.73% $2,189,449,648
WELLS FARGO & COMPANY/MN 0.52% 9,127,140 +0.93% 0.43% $2,113,297,880

Institutional Holders of AbbVie Inc. - Common Stock (ABBV) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 42,120,678 $9,617,791,380 -$409,556,690 $228.49 960
2025 Q3 1,269,475,738 $293,671,005,777 -$3,153,006,176 $231.54 3,852
2025 Q2 1,287,075,518 $238,891,433,790 +$4,866,082,367 $185.62 3,742
2025 Q1 1,259,174,906 $263,537,490,586 -$2,146,923,492 $209.52 3,757
2024 Q4 1,272,457,284 $226,103,722,919 +$5,227,952,139 $177.70 3,662
2024 Q3 1,237,910,814 $244,266,931,117 -$4,550,906,978 $197.48 3,455
2024 Q2 1,262,643,002 $216,458,860,926 +$5,771,342,009 $171.52 3,308
2024 Q1 1,226,322,864 $223,000,432,578 -$1,132,044,587 $182.10 3,350
2023 Q4 7,159,900 $1,109,282,685 +$148,632,795 $154.97 58
2023 Q3 1,204,327,413 $179,533,920,669 +$1,109,447,853 $149.06 3,043
2023 Q2 1,190,440,186 $160,627,462,604 -$4,629,907,971 $134.73 3,008
2023 Q1 1,203,460,923 $191,744,819,065 -$60,531,395 $159.37 3,070
2022 Q4 1,206,387,810 $194,915,130,557 +$2,811,072,635 $161.61 3,098
2022 Q3 1,190,125,182 $159,921,605,389 +$793,570,840 $134.21 2,910
2022 Q2 1,079,455,027 $165,245,597,123 +$2,647,703,611 $153.16 2,945
2022 Q1 1,069,402,793 $173,334,356,325 +$2,314,249,732 $162.11 2,992
2021 Q4 1,057,050,945 $143,087,307,788 +$940,141,924 $135.40 2,927
2021 Q3 1,174,684,588 $126,737,363,489 -$406,883,100 $107.87 2,617
2021 Q2 1,179,654,729 $132,842,344,945 -$634,639,914 $112.64 2,637
2021 Q1 1,183,666,367 $128,068,093,034 -$1,089,375,554 $108.22 2,577
2020 Q4 1,196,287,593 $128,130,099,671 -$1,059,126,979 $107.15 2,558
2020 Q3 1,198,078,929 $104,873,409,014 -$1,244,500,321 $87.59 2,337
2020 Q2 1,193,469,012 $117,078,211,628 +$14,532,143,073 $98.18 2,381
2020 Q1 1,074,598,931 $81,882,348,417 +$954,623,533 $76.19 2,194
2019 Q4 1,066,546,329 $94,408,391,738 +$1,217,101,482 $88.54 2,216
2019 Q3 1,018,808,072 $77,132,262,880 +$1,724,459,163 $75.72 1,981
2019 Q2 1,010,491,233 $73,440,300,299 +$1,420,698,871 $72.72 1,997
2019 Q1 1,004,532,042 $80,944,815,429 -$1,917,612,671 $80.59 2,006
2018 Q4 1,033,891,463 $95,211,216,372 -$2,251,079,601 $92.19 2,039
2018 Q3 1,060,446,545 $100,240,449,095 -$305,029,431 $94.58 1,938
2018 Q2 1,059,061,686 $98,094,806,185 -$3,386,593,851 $92.65 1,970
2018 Q1 1,104,217,010 $104,472,355,033 -$1,229,901,037 $94.65 1,995
2017 Q4 1,124,001,555 $108,680,436,336 +$367,910,290 $96.71 1,975
2017 Q3 1,118,080,445 $99,345,861,262 +$1,309,817,176 $88.86 1,783
2017 Q2 1,102,112,376 $79,894,245,339 +$1,018,741,247 $72.51 1,752
2017 Q1 1,095,470,117 $71,379,574,999 +$5,871,638,041 $65.16 1,716
2016 Q4 1,091,691,593 $68,345,785,924 -$1,526,044,663 $62.62 1,678
2016 Q3 1,112,733,266 $70,124,308,435 -$876,335,552 $63.07 1,633
2016 Q2 1,125,933,508 $69,684,420,184 +$1,406,551,617 $61.91 1,619
2016 Q1 1,103,279,470 $63,014,506,317 -$315,051,186 $57.12 1,619
2015 Q4 1,114,759,195 $66,028,405,040 -$1,783,986,992 $59.24 1,624
2015 Q3 1,135,113,708 $61,761,180,242 -$3,032,168,459 $54.41 1,583
2015 Q2 1,171,774,927 $78,733,792,761 +$5,878,687,366 $67.19 1,638
2015 Q1 1,110,817,245 $65,049,293,998 -$605,661,065 $58.54 1,584
2014 Q4 1,117,323,035 $73,114,384,391 -$8,407,801,996 $65.44 1,589
2014 Q3 1,251,611,224 $72,289,182,505 +$8,365,052,536 $57.76 1,488
2014 Q2 1,110,137,226 $62,648,141,304 +$2,618,680,900 $56.44 1,444
2014 Q1 1,066,647,842 $54,812,170,585 +$12,099,821 $51.40 1,408